Articles tagged with "Golimumab"

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

October 21, 2020 • By Michele B. Kaufman, PharmD, BCGP

2 Pediatric Indications Sought for Golimumab

June 3, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin

November 20, 2019 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

August 16, 2019 • By Mary Choy, PharmD, BCGP, FASHP

Biological DMARDs in Elderly RA Patients: Use, Maintenance & Discontinuation

June 17, 2019

kenary820 / shutterstock.com

Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis

April 15, 2019 • By Mary Choy, PharmD, BCGP, FASHP

Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab

December 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Johnson & Johnson Discloses U.S. Probe Related to Arthritis Drugs

May 12, 2017 • By Reuters Staff

High Cost of Rheumatoid Arthritis Medications Burdens Patients in Saudi Arabia

March 20, 2017 • By Lina El Kibbi

FDA Releases Biosimilar Guidance, Medicare Will Cover Infliximab-dyyb & More

January 18, 2017 • By Michele B. Kaufman, PharmD, BCGP